Location: New York, NY
CIK: 0001952142 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value: $334M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,731,191 | $33.33M | 10.0% | $17.34 | +19.1% | COM | 87164F105 |
| ROIV | ROIVANT SCIENCES LTD | 2,769,819 | $31.96M | 9.6% | $10.18 | +11.9% | SHS | G76279101 |
| — | MERUS N V | 421,222 | $21.04M | 6.3% | $38.69 | — | COM | N5749R100 |
| IMVT | IMMUNOVANT INC | 671,001 | $19.13M | 5.7% | $33.53 | -12.0% | COM | 45258J102 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,778,318 | $16.54M | 5.0% | $5.99 | +64.8% | COM | 03969K108 |
| FOLD | AMICUS THERAPEUTICS INC | 1,481,809 | $15.83M | 4.7% | $11.99 | -9.2% | COM | 03152W109 |
| BMY | BRISTOL-MYERS SQUIBB CO | 275,303 | $14.24M | 4.3% | $43.65 | 0.0% | COM | 110122108 |
| — | APPLIED THERAPEUTICS INC | 1,554,586 | $13.21M | 4.0% | $5.20 | — | COM | 03828A101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 213,815 | $10.93M | 3.3% | $35.72 | +44.4% | COM | 22663K107 |
| BHVN | BIOHAVEN LTD | 216,440 | $10.82M | 3.2% | $36.52 | +6.5% | COM | G1110E107 |
| PRAX | PRAXIS PRECISION MEDICINES I | 174,034 | $10.01M | 3.0% | $52.51 | +2.9% | COM NEW | 74006W207 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2,616,602 | $9.498M | 2.8% | $6.39 | — | SPON ADS | 05280R100 |
| INCY | INCYTE CORP | 129,490 | $8.559M | 2.6% | $63.77 | 0.0% | COM | 45337C102 |
| DNLI | DENALI THERAPEUTICS INC | 282,050 | $8.216M | 2.5% | $19.81 | +25.1% | COM | 24823R105 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 506,978 | $7.062M | 2.1% | $14.27 | 0.0% | COM | 23954D109 |
| — | ACELYRIN INC | 1,317,854 | $6.497M | 1.9% | $4.93 | — | COM | 00445A100 |
| SLNO | SOLENO THERAPEUTICS INC | 123,177 | $6.219M | 1.9% | $47.87 | 0.0% | COM | 834203309 |
| CABA | CABALETTA BIO INC | 1,278,444 | $6.034M | 1.8% | $17.34 | -66.6% | COM | 12674W109 |
| IMTX | IMMATICS N.V | 449,735 | $5.131M | 1.5% | $9.25 | +28.0% | SHS | N44445109 |
| KROS | KEROS THERAPEUTICS INC | 86,930 | $5.048M | 1.5% | $49.39 | 0.0% | COM | 492327101 |
| ACLX | ARCELLX INC | 60,076 | $5.017M | 1.5% | $49.74 | +33.9% | COMMON STOCK | 03940C100 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,846,792 | $4.901M | 1.5% | $3.82 | -10.6% | COM | 92840H400 |
| NRIX | NURIX THERAPEUTICS INC | 203,015 | $4.562M | 1.4% | $15.57 | +45.5% | COM | 67080M103 |
| TCRX | TSCAN THERAPEUTICS INC | 860,951 | $4.288M | 1.3% | $7.84 | -23.1% | COM | 89854M101 |
| ZURA | ZURA BIO LTD | 1,044,168 | $4.239M | 1.3% | $3.74 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| IDYA | IDEAYA BIOSCIENCES INC | 132,703 | $4.204M | 1.3% | $41.45 | -8.5% | COM | 45166A102 |
| TERN | TERNS PHARMACEUTICALS INC | 449,321 | $3.747M | 1.1% | $8.23 | 0.0% | COM | 880881107 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 238,084 | $3.178M | 1.0% | $14.46 | -8.0% | COM NEW | 46489V302 |
| PYXS | PYXIS ONCOLOGY INC | 850,210 | $3.12M | 0.9% | $4.21 | -16.8% | COMMON STOCK | 747324101 |
| NGNE | NEUROGENE INC | 73,299 | $3.076M | 0.9% | $35.27 | +10.0% | COM | 64135M105 |
| URGN | UROGEN PHARMA LTD | 241,984 | $3.073M | 0.9% | $14.84 | 0.0% | COM | M96088105 |
| — | VIGIL NEUROSCIENCE INC | 743,719 | $2.529M | 0.8% | $4.00 | — | COM | 92673K108 |
| WVE | WAVE LIFE SCIENCES LTD | 300,000 | $2.46M | 0.7% | $5.98 | 0.0% | SHS | Y95308105 |
| BBIO | BRIDGEBIO PHARMA INC | 94,885 | $2.416M | 0.7% | $26.25 | 0.0% | COM | 10806X102 |
| JANX | JANUX THERAPEUTICS INC | 49,415 | $2.245M | 0.7% | $21.78 | +99.8% | COM | 47103J105 |
| SRZN | SURROZEN INC | 182,918 | $2.191M | 0.7% | $10.00 | -11.7% | COM NEW | 86889P208 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 41,268 | $2.162M | 0.6% | $47.92 | 0.0% | COM | 76243J105 |
| BBOT | HELIX ACQUISITION CORP II | 200,000 | $2.09M | 0.6% | $10.35 | +0.1% | CL A ORD SHS | G4444H101 |
| SRPT | SAREPTA THERAPEUTICS INC | 15,014 | $1.875M | 0.6% | $138.24 | 0.0% | COM | 803607100 |
| TARA | PROTARA THERAPEUTICS INC | 942,857 | $1.725M | 0.5% | $2.98 | -31.0% | COM STK | 74365U107 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 150,000 | $1.503M | 0.4% | $10.07 | -0.1% | CL A ORD SHS | G70077105 |
| — | TOURMALINE BIO INC | 55,523 | $1.427M | 0.4% | $25.71 | — | COM | 89157D105 |
| CAPR | CAPRICOR THERAPEUTICS INC | 93,638 | $1.424M | 0.4% | $4.95 | 0.0% | COM NEW | 14070B309 |
| ALKS | ALKERMES PLC | 48,918 | $1.369M | 0.4% | $26.66 | 0.0% | SHS | G01767105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 83,662 | $1.338M | 0.4% | $15.99 | — | SPONSORED ADS | 152309100 |
| MBX | MBX BIOSCIENCES INC | 50,000 | $1.299M | 0.4% | $22.87 | 0.0% | COM | 55287L101 |
| CYTK | CYTOKINETICS INC | 14,464 | $764K | 0.2% | $55.74 | 0.0% | COM NEW | 23282W605 |
| RVMD | REVOLUTION MEDICINES INC | 16,654 | $755K | 0.2% | $43.54 | 0.0% | COM | 76155X100 |
| — | ASTRIA THERAPEUTICS INC | 56,287 | $619K | 0.2% | $11.00 | — | COM | 04635X102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 19,900 | $531K | 0.2% | $17.44 | +14.1% | COM | 28036F105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 230,000 | $382K | 0.1% | $17.34 | +19.1% | Call | 87164F105 |
| IMVT | IMMUNOVANT INC | 200,000 | $113K | 0.0% | $33.53 | -12.0% | Call | 45258J102 |
| — | APPLIED THERAPEUTICS INC | 251,600 | $75,480 | 0.0% | $5.20 | — | Call | 03828A101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 250,000 | $12,500 | 0.0% | $5.99 | +64.8% | Call | 03969K108 |